Terms: = Colorectal cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272
82 results:
1. Association of Life Expectancy With Surveillance Colonoscopy Findings and Follow-up Recommendations in Older Adults.
Calderwood AH; Tosteson TD; Wang Q; Onega T; Walter LC
JAMA Intern Med; 2023 May; 183(5):426-434. PubMed ID: 36912828
[TBL] [Abstract] [Full Text] [Related]
2. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ
Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091
[TBL] [Abstract] [Full Text] [Related]
3. Investigation of the expression levels of CDH1, fhit, PTEN, and TTPAL genes in colorectal tumors.
Arıkan Söylemez ESS; Söylemez Z; Çilekar M; Arıkan Y; Tokyol Ç; Kenger İH; Solak M
Turk J Med Sci; 2022 Feb; 52(1):124-130. PubMed ID: 36161592
[TBL] [Abstract] [Full Text] [Related]
4. Tanshinones induce tumor cell apoptosis via directly targeting fhit.
Zhou X; Pan Y; Wang Y; Wang B; Yan Y; Qu Y; Ke X
Sci Rep; 2021 Jun; 11(1):12217. PubMed ID: 34108553
[TBL] [Abstract] [Full Text] [Related]
5. Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes.
Aldersley J; Lorenz DR; Mouw KW; D'Andrea AD; Gabuzda D
Mol Cancer Res; 2021 Aug; 19(8):1308-1321. PubMed ID: 33883185
[TBL] [Abstract] [Full Text] [Related]
6. RBP EIF2S2 Promotes Tumorigenesis and Progression by Regulating MYC-Mediated Inhibition via fhit-Related Enhancers.
Zhang J; Li S; Zhang L; Xu J; Song M; Shao T; Huang Z; Li Y
Mol Ther; 2020 Apr; 28(4):1105-1118. PubMed ID: 32059763
[TBL] [Abstract] [Full Text] [Related]
7. fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells.
Druck T; Cheung DG; Park D; Trapasso F; Pichiorri F; Gaspari M; Palumbo T; Aqeilan RI; Gaudio E; Okumura H; Iuliano R; Raso C; Green K; Huebner K; Croce CM
Cell Death Dis; 2019 Feb; 10(3):147. PubMed ID: 30770797
[TBL] [Abstract] [Full Text] [Related]
8. In vivo identification of novel TGIF2LX target genes in colorectal adenocarcinoma using the cDNA-AFLP method.
Mobini GR; Ghafari A; Amanpour S; Fateh R; Ghahremani MH; Muhammadnejad S; Dehpour AR; Akbari A; Hoseiniharouni SM; Kazemirad E; Bolhassani M; Heidari M
Arab J Gastroenterol; 2018 Jun; 19(2):65-70. PubMed ID: 29960902
[TBL] [Abstract] [Full Text] [Related]
9. Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients.
Le Saux O; Bourmaud A; Rioufol C; Colomban O; Guitton J; Schwiertz V; Regnier V; You B; Ranchon F; Maraval-Gaget R; Girard P; Chauvin F; Freyer G; Tod M; Henin E; Trillet-Lenoir V
Cancer Chemother Pharmacol; 2018 Aug; 82(2):319-327. PubMed ID: 29948022
[TBL] [Abstract] [Full Text] [Related]
10. Do fhit gene alterations play a role in human solid tumors?
Silveira Zavalhia L; Weber Medeiros A; Oliveira Silva A; Vial Roehe A
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e214-e223. PubMed ID: 29516675
[TBL] [Abstract] [Full Text] [Related]
11. In silico analysis of fragile histidine triad involved in regression of carcinoma.
Rasheed MA; Tariq F; Afzal S; Mannanv S
J Pak Med Assoc; 2017 Apr; 67(4):616-621. PubMed ID: 28420927
[TBL] [Abstract] [Full Text] [Related]
12. Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer.
Swan R; Alnabulsi A; Cash B; Alnabulsi A; Murray GI
Oncotarget; 2016 Jul; 7(29):46509-46527. PubMed ID: 27341022
[TBL] [Abstract] [Full Text] [Related]
13. Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of colorectal cancer Cell Lines to Identify Novel Biomarkers.
Briffa R; Um I; Faratian D; Zhou Y; Turnbull AK; Langdon SP; Harrison DJ
PLoS One; 2015; 10(12):e0144708. PubMed ID: 26678268
[TBL] [Abstract] [Full Text] [Related]
14. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma.
Kara M; Yumrutas O; Ozcan O; Celik OI; Bozgeyik E; Bozgeyik I; Tasdemir S
Gene; 2015 Aug; 567(1):81-6. PubMed ID: 25925209
[TBL] [Abstract] [Full Text] [Related]
15. Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence.
Rengucci C; De Maio G; Casadei Gardini A; Zucca M; Scarpi E; Zingaretti C; Foschi G; Tumedei MM; Molinari C; Saragoni L; Puccetti M; Amadori D; Zoli W; Calistri D
J Exp Clin Cancer Res; 2014 Aug; 33(1):65. PubMed ID: 25091577
[TBL] [Abstract] [Full Text] [Related]
16. A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients.
Kim SK; Kim SY; Kim JH; Roh SA; Cho DH; Kim YS; Kim JC
Mol Oncol; 2014 Dec; 8(8):1653-66. PubMed ID: 25049118
[TBL] [Abstract] [Full Text] [Related]
17. Reduced fhit expression is associated with tumor progression in sporadic colon adenocarcinoma.
Kapitanović S; Čačev T; Lončar B; Catela Ivković T; Križanac Š; Pavelić K
Exp Mol Pathol; 2014 Feb; 96(1):92-7. PubMed ID: 24370550
[TBL] [Abstract] [Full Text] [Related]
18. Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases.
Virzì S; Iusco D; Baratti D; Bonomi S; Grassi A; Kusamura S; Deraco M
Tumori; 2013; 99(5):589-95. PubMed ID: 24362862
[TBL] [Abstract] [Full Text] [Related]
19. [Incidence and mortality of cancer in Zhejiang province in 2009].
Li HZ; Mao WM; Wang XH; Yu CD; Du LB
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Jul; 47(7):592-6. PubMed ID: 24304949
[TBL] [Abstract] [Full Text] [Related]
20. Reduced fhit expression is associated with mismatch repair deficient and high CpG island methylator phenotype colorectal cancer.
Al-Temaimi RA; Jacob S; Al-Ali W; Thomas DA; Al-Mulla F
J Histochem Cytochem; 2013 Sep; 61(9):627-38. PubMed ID: 23797051
[TBL] [Abstract] [Full Text] [Related]
[Next]
